dementia
Metabolon Partners With Swedish Biofinder 2 Study to Develop Dementia Biomarkers
The company will run metabolomics on cerebrospinal fluid and plasma from the study's baseline collections to identify biomarkers.
Amprion Partners With Mayo Clinic to Evaluate Biomarker Test in Rapidly Progressive Dementia
Amprion's test was launched in late 2021 and is designed to detect alpha-synuclein aggregates, a hallmark of various brain diseases.
Researchers at NIH’s newly established Center for Alzheimer's and Related Dementias are using nanopore sequencing to analyze thousands of brain samples.
Centogene, Alector Partner to ID Frontotemporal Dementia Patients With Genetic Mutations
The EFRONT study aims to enroll more than 3,000 FTD patients for genetic testing at centers in Belgium, Germany, Greece, Italy, Portugal, Spain, and Turkey.
NIH, Genomics England Launch Large-Scale Human Genome Sequencing Studies Using Nanopore Technology
The research projects will use Oxford Nanopore Technologies' PromethIon 48 instrument to sequence genomes of patients with dementia and cancer, respectively.